分组1 - Merit Medical reported quarterly earnings of $1.04 per share, exceeding the Zacks Consensus Estimate of $0.96 per share, and showing an increase from $0.93 per share a year ago, resulting in an earnings surprise of +8.90% [1] - The company achieved revenues of $393.94 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.80%, and up from $355.16 million year-over-year [2] - Merit Medical has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] 分组2 - The stock has underperformed the market, losing about 7.4% since the beginning of the year, compared to a decline of 0.1% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $0.89 on revenues of $379.6 million, and for the current fiscal year, it is $4.05 on revenues of $1.6 billion [7] - The Medical - Dental Supplies industry, to which Merit Medical belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

分组1 - Merit Medical reported quarterly earnings of $0.86 per share, exceeding the Zacks Consensus Estimate of $0.75 per share, and showing an increase from $0.77 per share a year ago, resulting in an earnings surprise of 14.67% [1] - The company achieved revenues of $355.35 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.86% and up from $323.51 million year-over-year [2] - Merit Medical has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has experienced a decline of approximately 3.1% since the beginning of the year, while the S&P 500 has declined by 8.6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.95, with expected revenues of $373.97 million, and for the current fiscal year, the EPS estimate is $3.66 on revenues of $1.48 billion [7] - The Medical - Dental Supplies industry is currently ranked in the bottom 42% of over 250 Zacks industries, indicating potential challenges for stock performance [8]